The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Trifluoperazine for schizophrenia
|
---|---|
Published in |
Cochrane database of systematic reviews, January 2004
|
DOI | 10.1002/14651858.cd003545.pub2 |
Pubmed ID | |
Authors |
Luciana de Oliveira Marques, Bernardo Soares, Mauricio Silva de Lima |
Abstract |
Trifluoperazine is an inexpensive accessible 'high potency' antipsychotic drug, widely used to treat schizophrenia or related psychoses. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 40% |
Australia | 1 | 20% |
India | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Practitioners (doctors, other healthcare professionals) | 1 | 20% |
Mendeley readers
The data shown below were compiled from readership statistics for 153 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 153 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 27 | 18% |
Student > Bachelor | 17 | 11% |
Researcher | 14 | 9% |
Student > Ph. D. Student | 9 | 6% |
Student > Doctoral Student | 9 | 6% |
Other | 24 | 16% |
Unknown | 53 | 35% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 34 | 22% |
Psychology | 19 | 12% |
Nursing and Health Professions | 13 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 10 | 7% |
Biochemistry, Genetics and Molecular Biology | 4 | 3% |
Other | 16 | 10% |
Unknown | 57 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2020.
All research outputs
#5,829,853
of 26,731,031 outputs
Outputs from Cochrane database of systematic reviews
#7,857
of 13,270 outputs
Outputs of similar age
#18,616
of 152,595 outputs
Outputs of similar age from Cochrane database of systematic reviews
#24
of 51 outputs
Altmetric has tracked 26,731,031 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,270 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.8. This one is in the 39th percentile – i.e., 39% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 152,595 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 51 others from the same source and published within six weeks on either side of this one. This one is in the 47th percentile – i.e., 47% of its contemporaries scored the same or lower than it.